Gevorg Tamamyan – Launching Hemostasis Today, The New Voice in Hemostasis and Thrombosis
Gevorg Tamamyan, Co-founder and Editor in Chief of OncoDaily, shared an honoring post on LinkedIn:
“In 2 years OncoDaily became the leading news outlet of oncology, opened the doors for everyone and became the voice of oncology. Now the time is for the Hemostasis Today! Hemostasis Today (HT) will be the daily voice of hemostasis and thrombosis world.
We started Hemostasis Today just 2 months ago and in 2 months it became already a very popular platform in the community. Below is the total engagement metrics on LinkedIn for the last 30 days, comparing its activity with leading global news and scientific publication pages.
Hemostasis Today is a proud member of OncoDaily family.
Soon we will launch also the Hemostasis Today TV, Hemostasis Today Magazine and the Medical Journal.
If you are interested to be part of our journey, please, connect with us. We will be more than happy for that.”
Stay informed with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!